TrialThe Journal of clinical investigation2015

Fresolimumab treatment decreases biomarkers and improves clinical symptoms in systemic sclerosis patients.

Lisa M Rice et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.